Compare Amgen, Inc. (AMGN) vs SMX Security Matters plc (SMX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs SMX Security Matters plc — how do they compare? Amgen, Inc. trades at $366.75 (market cap $196.12B), while SMX Security Matters plc trades at $15.49 (market cap $15.03M). The key difference: Amgen, Inc. is far larger — about 13048.6× SMX Security Matters plc's market cap, and Amgen, Inc. pays a 2.77% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| AMGN | SMX | |
|---|---|---|
Market Cap | $196.12B | $15.03M |
Sector | Health | Technology |
52-Week High | $388.16 | $313.26K |
52-Week Low | $271.18 | $12.87 |
Enterprise Value | $241.41B | $12.00M |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
SMX trades at $15.65, down 4.02% in the last session, with a neutral technical signal and bearish moving averages. The stock shows negative profitability with a ROE of -2,216.26% and ROA of -398.22%, while the P/B ratio stands at 1.7. Recent corporate actions include two reverse stock splits in May and June 2026. News highlights the company's focus on recycled plastic traceability amid new state recycling mandates, positioning it in a growing regulatory environment.
The outlook for SMX is challenged by weak profitability but supported by potential demand from recycling regulations. Investment opportunity lies in policy-driven adoption of its traceability technology, while risks include execution hurdles and sustained negative returns. The stock's near-term direction may hinge on converting regulatory tailwinds into tangible financial improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
